Form 4: Myriad Genetics Executive Receives Stock Grant

Sentiment:

Insider Transaction (Form 4)


Shereen Solaiman, Chief People Officer of Myriad Genetics Inc, received 83,049 shares of common stock on November 6, 2026.

Summary

  • Grant/award: acquired 83,049 Time-Based Stock Option on November 6, 2026; holds 83,049 after (Direct).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

Shereen Solaiman — Officer (Chief People Officer)

DateTransactionSecuritySharesPriceValueHeld After
2026-11-06Grant/awardTime-Based Stock Option83,049——83,049

Key Dates

DateDescription
2026-11-06Grant/award (83,049 shares)

Keywords

insider transaction, Form 4, MYGN, MYRIAD GENETICS INC, neutral, Shereen Solaiman

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.